+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 5 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are evaluating how well once-weekly insulin icodec maintains blood sugar levels compared to daily basal insulin injections in adults with type 2 diabetes. The study focuses on people who need to start basal insulin treatment after using other glucose-lowering medications. This phase 4 trial aims to assess insulin icodecs effectiveness in real-world clinical practice over about 13 months. Participants will be randomly assigned to receive either weekly subcutaneous injections of insulin icodec or daily subcutaneous injections of basal insulin analogues such as insulin glargine, detemir, or degludec. The study compares these two insulin regimens as part of standard type 2 diabetes care. Treatment continues during the 52-week period to monitor blood sugar control and treatment satisfaction. Throughout the study, participants will undergo assessments including measuring changes in glycated hemoglobin HbA1c from baseline to week 52. They will also complete questionnaires on treatment adherence, satisfaction, and burden, and researchers will track severe hypoglycemia episodes and insulin doses. The trial spans about 13 months, providing thorough monitoring of treatment impact and safety in daily clinical use.

Age: 18Years +All GendersPhase 4
75 locations
B

Actively Recruiting

Researchers are evaluating blood biomarkers related to Alzheimers Disease and neuro-injury to understand their association with cognitive and functional decline, mortality, and hospital readmission in older hospitalized patients. This multicenter, prospective observational study aims to validate a prognostic algorithm developed from a prior retrospective analysis of biomarkers in a cohort of 700 geriatric patients. The study integrates clinical, laboratory, and biomarker data to assess these relationships in a real-world population. The study involves three groups of hospitalized patients those with acute neurological disorders such as stroke or delirium, those with major neurocognitive disorder dementia, and those hospitalized for non-neurological diseases without dementia. Blood samples will be collected at baseline to measure amyloid -42, tau proteins, neuro-injury markers, neuroinflammation markers, and astrocyte activation. The research will observe participants over 12 months to record mortality and hospital readmission rates. Participants will undergo comprehensive geriatric assessments and evaluations of cognitive function and frailty at the start of the study. Blood biomarker levels will be analyzed alongside clinical data to explore their association with outcomes. The primary outcomes include all-cause mortality and number of hospital readmissions within 12 months of enrollment. This observational study does not involve treatment interventions but focuses on monitoring and data collection to improve understanding of disease progression and risks in elderly hospitalized patients.

Age: 65Years +All Genders
3 locations
E

Actively Recruiting

This research aims to enhance self-management skills for adults with Type 2 Diabetes Mellitus T2DM living in the Marche region of Italy. It evaluates a mobile health m-health solution personalized by diabetologists and integrated with electronic patient records, comparing its use to usual diabetes care. The main goal is to measure changes in glycated haemoglobin HbA1c levels over a 12-month period to assess the effectiveness of this digital support. Participants will be randomly assigned to either a treated group using the m-health solution or a control group receiving regular care. The m-health system includes mobile apps for tracking health data such as blood sugar, physical activity, and diet, sending alerts and motivational messages, allowing communication with healthcare professionals, and providing access to educational materials. Healthcare providers will monitor patient data through an integrated electronic platform. The treatment lasts 12 months with evaluations at baseline, 4, 8, and 12 months. During the study, participants will engage in clinical assessments and complete validated questionnaires covering disease severity, medication adherence, lifestyle habits, self-efficacy, and quality of life. Data will be collected from self-reports, clinical visits, and the m-health app. Researchers will also explore patients experience and satisfaction with the m-health solution and assess its cost-effectiveness. No extra visits or lab tests beyond routine care are required.

Age: 18Years +All GendersPhase Not Applicable
11 locations
R

Actively Recruiting

Parkinsons disease is a common cause of disability in older adults, characterized by motor problems including balance issues that do not improve with standard dopaminergic treatments. This research aims to explore new rehabilitation methods using robotic devices to enhance gait and reduce fall risk in elderly patients with Parkinsons disease. The study is a single-blinded randomized controlled trial involving 195 patients, designed to assess the effectiveness of these innovative approaches. Participants will be randomly assigned to one of three groups a control group receiving traditional rehabilitation therapy, a group using the Tymo system robotic device combined with traditional therapy, or a group using the Walker View robotic treadmill alongside traditional therapy. Each participant will complete 10 treatment sessions over 5 weeks, with two sessions per week. The control group will receive 50 minutes of traditional therapy per session, while the robotic groups will receive 30 minutes of traditional therapy plus 20 minutes with their assigned robotic device. Throughout the study, patients will be evaluated at the start, after treatment, and during follow-ups at 6 months, 1 year, and 2 years to monitor outcomes such as fall risk, gait performance, and fear of falling. Assessments include task-oriented exercises using robotic platforms and traditional therapy, with long-term monitoring to understand sustained effects. This approach supports understanding how robotic rehabilitation may influence motor function and safety in elderly Parkinsons patients over time.

Age: 65Years +All GendersPhase Not Applicable
2 locations
E

Actively Recruiting

Researchers are evaluating a program designed to improve the abilities and well-being of older adults with mild cognitive impairment MCI by engaging them in innovative activities inspired by the Montessori method within rural farming environments. This approach aims to involve both individuals and their families in a personalized therapeutic journey that promotes cognitive and motor skills while supporting a healthy lifestyle. The study is led by the Istituto Nazionale di Ricovero e Cura per Anziani and focuses on enhancing intrinsic capacities in elderly participants. The intervention includes a nine-month program of social activities conducted three days a week, each lasting five hours. These activities incorporate horticulture, pet therapy, occupational therapy, sensory and food laboratories, physical exercise, and continuous social engagement across generations. All activities take place in a rural setting chosen for its educational features and agricultural multifunctionality, offering participants a rich, stimulating environment. Participants will be assessed at the start and after nine months to measure changes in positive and negative emotions. Throughout the study, researchers will monitor cognitive and physical responses to the activities, including adherence and engagement with the program. The total participation involves regular involvement in these activities and assessments over the nine-month period, aiming to understand how these interventions impact mood and cognitive function in people with MCI.

Age: 55Years +All GendersPhase Not Applicable
2 locations